Evolent Health, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Evolent Health, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Evolent Health, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $9.91M, a 63.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $9.91M -$17.6M -63.9% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $10.8M -$33.6M -75.7% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $12M -$37M -75.6% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $17.4M -$33.3M -65.7% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $27.5M -$23.4M -46% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $44.4M -$4.08M -8.41% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $49M -$1.18M -2.34% Dec 31, 2022 10-K 2024-02-23
Q3 2022 $50.7M +$578K +1.15% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $50.9M -$1.03M -1.99% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $48.5M -$5.2M -9.69% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $50.2M -$7.6M -13.1% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $50.1M -$10.1M -16.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $51.9M -$14.2M -21.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $53.7M -$9.35M -14.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $57.8M -$14.4M -19.9% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $60.2M -$15.5M -20.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $66.1M -$10.6M -13.8% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $63M -$817K -1.28% Mar 31, 2020 10-Q 2020-05-28
Q4 2019 $72.2M +$72.2M Dec 31, 2019 10-K 2021-02-26
Q3 2019 $75.8M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $76.7M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $63.9M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.